Marksans Pharma Shares Skyrocket 9% on USFDA Approval
April 1, 2026April 1, 2026 Shares of Marksans Pharma Ltd skyrocketed 9% on 1 April after the firm announced that its Benzonatate Capsules had received approval from the US Food and Drug Administration (USFDA). The firm announced that it had acquired final approval from the US Food and Drug…
